You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • TP003/#1557  An open label, single arm, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16 or 18 positive cervical cancer (DURBAC)

Article info

Article menu

Download PDFPDF

ePoster Viewing: Trials-in-Progress
AS03. Cervical cancer
TP003/#1557  An open label, single arm, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16 or 18 positive cervical cancer (DURBAC)
Free

Authors

Citation

Choi CH, Kim BG, Lee J, et al
TP003/#1557  An open label, single arm, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16 or 18 positive cervical cancer (DURBAC)
International Journal of Gynecologic Cancer 2023;33:A246.

Publication history

  • First published November 7, 2023.
Online issue publication 
November 07, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.